IMC Chicago’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
IMC Chicago's PPH Position: Q2 2026 in Review
IMC Chicago increased its VanEck Pharmaceutical ETF (PPH) stake by 94% in Q2 2026, buying an estimated $318K and bringing the position to 6,329 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #4278.
IMC Chicago first reported a position in PPH in Q3 2020 and has held it in 12 quarters since. The position peaked at $2.1M in Q2 2022. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- IMC Chicago held 6,329 shares of VanEck Pharmaceutical ETF worth $692K as of Q2 2026.
- IMC Chicago bought 3,072 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $318K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4278 holding.
- IMC Chicago first reported a position in VanEck Pharmaceutical ETF in Q3 2020 and has held it in 12 quarters since.
- IMC Chicago's VanEck Pharmaceutical ETF position peaked at $2.1M in Q2 2022.
- 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.